PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
11-Mar-2026 NASA Awards Redwire $4 Million In Additional Funding to Support Trailblazing Drug Development in Microgravity Businesswire
11-Mar-2026 AI Maverick Intel Announces Strategic Right of First Refusal Agreement with HEAL Group ACCESS Newswire
11-Mar-2026 Chiesi and Bespak Partner to Advance Carbon Minimal Inhaler Production With UK Manufacturing Site Businesswire
11-Mar-2026 Aplantex and Investissement Québec Team up to Produce Molecules for the Cosmetic and Food Industries Businesswire
11-Mar-2026 Brainomix Deploys AI Imaging Platform Across West Virginia University (WVU) Health System Network to Support Stroke Care Brainomix
11-Mar-2026 Cambridge Cognition Investment, Monument Therapeutics, Announces First Patient Dosed in Clinical Trial of MT1988 in Patients at Clinical High Risk for Psychosis Cambridge Cognition Investment
11-Mar-2026 National Health Service to offer VEOZA▼™ (fezolinetant) for the treatment of moderate-to-severe hot flushes and night-sweats associated with menopause when hormone replacement therapy is unsuitable. Astellas
11-Mar-2026 Commit Biologics appoints serial biotech founder as new CEO to take complement-powered immune engagers into the clinic Commit Biologics
11-Mar-2026 Chiesi and Bespak partner to advance Carbon Minimal Inhaler production with UK manufacturing site Bespak
11-Mar-2026 Codethink Opens Early Access to IEC 61508 Mapping for the Eclipse Trustable Software Framework Businesswire
11-Mar-2026 TRNR Completes Acquisition of Ergatta, Confirms Increased 2026 Pro Forma Revenue Guidance of $30m+ ACCESS Newswire
11-Mar-2026 Dr. Sean Doherty Recognized as Boston Magazine Top Doctors(TM) 2026 - Plastic Surgery ACCESS Newswire
11-Mar-2026 Jaguar Health Presenting March 12 at the Life Sciences Virtual Investor Forum to Provide Updates on Near-Term Catalysts ACCESS Newswire
11-Mar-2026 Curatis and Neupharma Announce Exclusive Licensing Agreement to Develop and Market Corticorelin (C-PTBE-01) for the Treatment of Peritumoral Brain Edema in Japan Businesswire
11-Mar-2026 FERM FOOD Acquires Orkla’s Former Site and Scales Up: Up to 20,000 Tonnes of Fermented Ingredients Per Year Businesswire
11-Mar-2026 EMA Grants PRIME Designation to TolerogenixX’s MIC-Lx Therapy for Donor-Specific Immune Tolerance in Kidney Transplantation TolerogenixX
11-Mar-2026 CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline ACCESS Newswire
11-Mar-2026 NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete ACCESS Newswire
11-Mar-2026 Wellgistics Strengthens PharmacyChain(TM) with Insurance Eligibility & Benefits Verification Capabilities ACCESS Newswire
11-Mar-2026 Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases ACCESS Newswire